The general office of Shanghai Municipal People’s government issued several policies and measures of Shanghai to fight the epidemic and help enterprises promote development, which proposed to support covid-19 virus vaccine, rapid detection reagent and special drugs to accelerate scientific and technological R & D and industrialization, and support the R & D and industrialization of covid-19 virus vaccine, drugs and diagnostic products through the municipal special funds for strategic emerging industries and special funds for high-quality industrial development.
The fastest antigen detection takes only about 15 minutes, which has the advantage of convenience and quickness. The main application scenarios of antigen detection are patient screening in grass-roots medical and health institutions that do not have the conditions for nucleic acid detection, early screening of isolation observers and self screening of community residents. Analysts pointed out that covid-19 detects huge orders for downstream products, and the relevant upstream and midstream industrial chains (such as antigen, antibody, NC membrane, packaging materials, etc.) will be deeply excavated by the market. Scientific research services and upstream raw materials are expected to run out of excess returns, while the same type of enterprises applying for household self-test antigen overseas will also be paid special attention.
According to the theme database of financial Associated Press, among the relevant listed companies:
Shanghai Kehua Bio-Engineering Co.Ltd(002022) is located in Shanghai. At present, antigen detection kits have obtained CE certification and are sold overseas. The registration certificate of Chinese covid-19 antigen detection products is under active application.
Shanghai Zj Bio-Tech Co.Ltd(688317) is located in Shanghai. The company successfully developed covid-19 virus nucleic acid detection reagent at the first time. The reagents, instruments and equipment are sold to more than 40 countries and regions around the world. The research and development of covid-19 dual antibody project of the company is in orderly progress.
